DE60113663D1 - Neue fettsäureanaloga - Google Patents
Neue fettsäureanalogaInfo
- Publication number
- DE60113663D1 DE60113663D1 DE60113663T DE60113663T DE60113663D1 DE 60113663 D1 DE60113663 D1 DE 60113663D1 DE 60113663 T DE60113663 T DE 60113663T DE 60113663 T DE60113663 T DE 60113663T DE 60113663 D1 DE60113663 D1 DE 60113663D1
- Authority
- DE
- Germany
- Prior art keywords
- carbon
- fatty acid
- alkyl
- coor2
- proviso
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 3
- 229930195729 fatty acid Natural products 0.000 title abstract 3
- 239000000194 fatty acid Substances 0.000 title abstract 3
- 150000004665 fatty acids Chemical class 0.000 title abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 6
- 229910052799 carbon Inorganic materials 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 208000004930 Fatty Liver Diseases 0.000 abstract 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000010706 fatty liver disease Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 abstract 1
- 201000008980 hyperinsulinism Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract 1
- 208000037804 stenosis Diseases 0.000 abstract 1
- 230000036262 stenosis Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C391/00—Compounds containing selenium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20001123 | 2000-03-03 | ||
| NO20001123A NO328803B1 (no) | 2000-03-03 | 2000-03-03 | Nye fettsyreanaloger |
| PCT/NO2001/000082 WO2001068582A1 (en) | 2000-03-03 | 2001-03-02 | Novel fatty acid analogous |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60113663D1 true DE60113663D1 (de) | 2006-02-09 |
| DE60113663T2 DE60113663T2 (de) | 2006-07-27 |
Family
ID=19910832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60113663T Expired - Lifetime DE60113663T2 (de) | 2000-03-03 | 2001-03-02 | Neue fettsäureanaloga |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7902399B2 (de) |
| EP (1) | EP1265838B9 (de) |
| JP (1) | JP5122050B2 (de) |
| KR (3) | KR100940373B1 (de) |
| CN (1) | CN1283611C (de) |
| AT (1) | ATE305447T1 (de) |
| AU (2) | AU2001237835B2 (de) |
| BR (1) | BR0108950A (de) |
| CA (1) | CA2401757C (de) |
| DE (1) | DE60113663T2 (de) |
| DK (1) | DK1265838T3 (de) |
| ES (1) | ES2250360T3 (de) |
| MX (1) | MX236472B (de) |
| NO (1) | NO328803B1 (de) |
| NZ (1) | NZ521137A (de) |
| RU (1) | RU2288215C2 (de) |
| WO (1) | WO2001068582A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO20004844L (no) | 2000-09-27 | 2002-05-10 | Thia Medica As | Fettsyre analoger for behandling av proliferative hudsykdommer |
| CA2490121C (en) | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
| AU2005209331A1 (en) * | 2004-01-30 | 2005-08-11 | Peplin Biolipids Pty Ltd | Therapeutic and carrier molecules |
| RU2388490C2 (ru) * | 2004-07-19 | 2010-05-10 | Тиа Медика Ас | Композиция, содержащая растительный или рыбий жир, и соединения, содержащие неокисляющиеся структурные элементы жирных кислот |
| NO324533B1 (no) * | 2004-07-19 | 2007-11-19 | Thia Medica As | Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og et proteinmateriale, samt anvendelse derav. |
| KR20070054637A (ko) * | 2004-07-19 | 2007-05-29 | 티아 메디카 에이에스 | 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물 |
| EP2217224B1 (de) | 2007-11-09 | 2019-05-08 | Basf As | Lipid-verbindungen zur verwendung in kosmetischen produkten, als nahrungsergänzungsmittel oder als medikament |
| NO20075894L (no) * | 2007-11-15 | 2009-05-18 | Thia Medica As | Redusert kjonnsmodning i fisk |
| EP2147910A1 (de) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Neue Lipid-Verbindungen |
| PL2427415T3 (pl) | 2009-05-08 | 2019-09-30 | Basf As | Wielonienasycone kwasy tłuszczowe do leczenia chorób związanych z dziedziną chorób sercowo-naczyniowych, metabolicznych i zapalnych |
| RU2402326C1 (ru) * | 2009-06-22 | 2010-10-27 | Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения Российской академии медицинских наук (ДНЦ ФПД СО РАМН) | Способ коррекции инсулинорезистентности при метаболическом синдроме |
| NZ610705A (en) | 2010-11-05 | 2014-10-31 | Pronova Biopharma Norge As | Methods of treatment using lipid compounds |
| KR102213143B1 (ko) | 2013-02-28 | 2021-02-08 | 바스프 에이에스 | 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법 |
| EP2968568A2 (de) | 2013-03-11 | 2016-01-20 | Life Science Nutrition AS | Natürliche lipide mit nicht oxidierbaren fettsäuren |
| AU2014228387B2 (en) | 2013-03-11 | 2016-09-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
| BR112017023164A2 (en) | 2015-04-28 | 2018-07-24 | Pronova Biopharma Norge As | and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof |
| BR112020011431A2 (pt) | 2017-12-06 | 2020-11-24 | Basf As | derivados de ácido graxo para o tratamento de esteato-hepatite não alcoólica |
| WO2020251368A1 (en) * | 2019-06-11 | 2020-12-17 | Rosi Charni As | Liposome formulation |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2210230A1 (de) * | 1972-03-03 | 1973-09-06 | Kolmar Laboratories | Verwendung bestimmter thioaether als antimikrobielle und zytostatische mittel |
| BE809894A (nl) | 1973-01-30 | 1974-07-18 | Antikleursluierstoffen voor fotografische kleurenmaterialen | |
| JPS5531778B2 (de) * | 1973-02-15 | 1980-08-20 | ||
| DE3620685A1 (de) | 1986-06-20 | 1987-12-23 | Henkel Kgaa | Neue mittel zur abdeckung unverletzter und/oder verletzter bereiche menschlicher oder tierischer haut |
| PT88053B (pt) | 1987-07-22 | 1995-03-01 | Roussel Uclaf | Processo para a preparacao de biciclo-octanos substituidos |
| FR2631339B1 (fr) | 1988-05-10 | 1990-11-16 | Cird | Nouveaux eicosanoides sulfures et leur application en pharmacie et en cosmetique |
| US5268494A (en) * | 1988-05-10 | 1993-12-07 | Centre International De Recherches Dermatologiques C.I.R.D. | Sulphur-containing eicosanoides and their application in pharmacy and in cosmetics |
| GB8813012D0 (en) * | 1988-06-02 | 1988-07-06 | Norsk Hydro As | Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals |
| JPH0379659A (ja) | 1989-08-22 | 1991-04-04 | Mitsubishi Gas Chem Co Inc | 光学用成形材料 |
| DE69027423T2 (de) | 1989-09-11 | 1997-02-06 | Kao Corp | Bleichzusammensetzung |
| CA2030174C (en) * | 1990-01-10 | 1996-12-24 | Anthony H. Cincotta | Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| JP3079659B2 (ja) | 1991-08-07 | 2000-08-21 | 松下電器産業株式会社 | 車載用空気清浄器 |
| US6602861B1 (en) | 1992-04-16 | 2003-08-05 | Research Corporation Technologies, Inc. | Acylated phospholipid drugs |
| US5554646A (en) * | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
| US5290960A (en) | 1993-02-25 | 1994-03-01 | The United States Of America As Represented By The Secretary Of The Navy | Diacetylenic phospholipids containing heteroatom near diacetylenic functionality for modulation of microstructure morphology |
| CN1088058C (zh) * | 1994-10-13 | 2002-07-24 | 肽技术有限公司 | 经修饰的多不饱和脂肪酸 |
| NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
| WO1997038688A1 (en) * | 1996-04-12 | 1997-10-23 | Peptide Technology Pty. Limited | Methods of treating immunopathologies using polyunsaturated fattyacids |
| AU3408097A (en) * | 1996-06-06 | 1998-01-05 | Ergo Research Corporation | Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists |
| AU7240398A (en) * | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
| JP2002519341A (ja) * | 1998-06-29 | 2002-07-02 | パーカー ヒューズ インスティテュート | 強力な抗がん剤としてのアルキルケトン類 |
| US6656498B1 (en) | 1998-11-25 | 2003-12-02 | Vanderbilt University | Cationic liposomes for gene transfer |
| FR2792312B1 (fr) | 1999-04-15 | 2001-06-08 | Oreal | Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation |
| AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
| NO20003591L (no) | 2000-07-13 | 2002-01-14 | Thia Medica As | Fettsyreanaloger for behandling av kreft |
| NO20004844L (no) | 2000-09-27 | 2002-05-10 | Thia Medica As | Fettsyre analoger for behandling av proliferative hudsykdommer |
| NO20006008L (no) | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
| US20020188023A1 (en) | 2000-12-12 | 2002-12-12 | Michael Jorgensen | Compound |
| GB0118517D0 (en) | 2001-07-30 | 2001-09-19 | Mitsubishi Tokyo Pharm Inc | Compound |
| FR2828487B1 (fr) | 2001-08-09 | 2005-05-27 | Genfit S A | Nouveaux composes derives d'acides gras, preparation et utilisations |
| CA2490121C (en) | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
| KR20070054637A (ko) | 2004-07-19 | 2007-05-29 | 티아 메디카 에이에스 | 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물 |
-
2000
- 2000-03-03 NO NO20001123A patent/NO328803B1/no not_active IP Right Cessation
-
2001
- 2001-03-02 KR KR1020087009732A patent/KR100940373B1/ko not_active Expired - Fee Related
- 2001-03-02 DK DK01910259T patent/DK1265838T3/da active
- 2001-03-02 AU AU2001237835A patent/AU2001237835B2/en not_active Ceased
- 2001-03-02 CA CA2401757A patent/CA2401757C/en not_active Expired - Fee Related
- 2001-03-02 KR KR1020097020038A patent/KR100982228B1/ko not_active Expired - Fee Related
- 2001-03-02 EP EP01910259A patent/EP1265838B9/de not_active Expired - Lifetime
- 2001-03-02 KR KR1020027011476A patent/KR100857626B1/ko not_active Expired - Fee Related
- 2001-03-02 AT AT01910259T patent/ATE305447T1/de active
- 2001-03-02 JP JP2001567680A patent/JP5122050B2/ja not_active Expired - Fee Related
- 2001-03-02 ES ES01910259T patent/ES2250360T3/es not_active Expired - Lifetime
- 2001-03-02 AU AU3783501A patent/AU3783501A/xx active Pending
- 2001-03-02 BR BR0108950-1A patent/BR0108950A/pt not_active Application Discontinuation
- 2001-03-02 WO PCT/NO2001/000082 patent/WO2001068582A1/en not_active Ceased
- 2001-03-02 MX MXPA02008629 patent/MX236472B/es active IP Right Grant
- 2001-03-02 DE DE60113663T patent/DE60113663T2/de not_active Expired - Lifetime
- 2001-03-02 RU RU2002123590/04A patent/RU2288215C2/ru not_active IP Right Cessation
- 2001-03-02 CN CNB018071112A patent/CN1283611C/zh not_active Expired - Fee Related
- 2001-03-02 NZ NZ521137A patent/NZ521137A/en not_active IP Right Cessation
- 2001-03-02 US US10/220,502 patent/US7902399B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60113663D1 (de) | Neue fettsäureanaloga | |
| ATE358982T1 (de) | Fett- oder ölzusammensetzung | |
| JP2007512376A5 (de) | ||
| JP2005504836A5 (de) | ||
| BR0112812A (pt) | Titanato de potássio e magnésio lepidocrocìtico, método para fabricar o mesmo e material de fricção | |
| NO20043548L (no) | Anvendelse av flerumettede katoner for behandling av psoriasis | |
| RU2000103224A (ru) | Лишенные побочных эффектов производные простагландинов для лечения глаукомы | |
| DE60137243D1 (de) | Fettsäure-analogen zur behandlung proliferierender hautstörungen | |
| ATE320802T1 (de) | Fettsäure-analoge zur behandlung von krebs | |
| WO2005089256A3 (en) | Antiangiogenic agents | |
| ES2421512T3 (es) | Composiciones orales que contienen compuestos antibacterianos bifenólicos | |
| EP0801049A3 (de) | Cyclopentanbutanolderivate als Duftstoffe | |
| DE60335089D1 (de) | Kohlenwasserstoffpolymerzusammensetzungen und formkörper | |
| WO2005118636A3 (en) | Tgf derepressors and uses related thereto | |
| BR0214917A (pt) | Composições que compreendem epotilonas e o uso das mesmas para o tratamento da sìndrome carcinóide | |
| EP1264594A3 (de) | Inhibitoren der Melaminherstellung und Hautpflegeprodukte, die solche Inhibitoren enthalten | |
| BRPI0601283A (pt) | composição para revestimento de pisos, aditivo para composição para revestimento de pisos, agente de nivelamento ou plastificante, e, método para melhorar o desempenho de nivelamento de uma composição para revestimento de pisos | |
| KR987000088A (ko) | HIV-1 감염증의 예방 및 치료를 위한 조성물 및 방법(Composition and Method for Prevention and Treatment of HIV-1 Infection) | |
| WO2003009820B1 (en) | Methods for promotion of hair growth comprising topical application of prostaglandin analogues | |
| NO20082546L (no) | Anvendelse av fettsyreanaloger | |
| JP2022113577A5 (de) | ||
| BR0309838A (pt) | composições microerbicidas e métodos de preparação e uso das mesmas | |
| BR0215861A (pt) | Composição de fluidização | |
| MX2025012350A (es) | Inhibidor cristalino de la lisina acetiltransferasa 6a (kat6a) y sus usos | |
| IT1306138B1 (it) | Composizione stabilizzante per benzine per inibire la formazione digomme. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |